Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (2) Cakmak-Görür, Nese Dr. (1) Daniel, Peter Prof. Dr. (3) Dhamodaran, Arunraj (1) Kammertöns, Thomas Dr. (9) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (3) Lorenz, Felix Dr. (1) Marko, Lajos Dr. (1) Poncette, Lucia (1) Schlag, Peter M. Prof. Dr. (1) Siffrin, Volker (1) Stein, Ulrike Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (8) Walther, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (10) (-) Blankenstein, Thomas Prof. Dr. (38) (-) Leisegang, Matthias Prof. Dr. rer. nat. (3) (-) Pezzutto, Antonio Prof. Dr. (7) (-) Rhein, Simone Dr. (1) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (18) Entwicklung Mechanismus-basierter Krebstherapien (1) Entwicklungsneurobiologie (1) Experimentelle Ultrahochfeld-MR (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Hochschulambulanz für Neuroimmunologie (1) Magnetic Resonance (1) (-) Molekulare Immunologie und Gentherapie (38) Proteom Dynamik (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Translational Bioinformatics (2) Translationale Onkologie solider Tumore (2) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) (-) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) (-) 2005 (10) 2006 (1) 2007 (5) (-) 2008 (5) 2009 (2) 2010 (7) (-) 2011 (5) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (4) (-) 2019 (6) 2020 (1) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 38 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Leisegang, Matthias Prof. Dr. rer. nat.Pezzutto, Antonio Prof. Dr.Rhein, Simone Dr.Molekulare Immunologie und Gentherapie 199820052008201120152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 01. Januar 1998 / Hum Gene Ther Strong immunogenic potential of a B7 retroviral expression vector: Generation of HLA-B7-restricted CTL response against selectable marker genes D. Jung E. Jaeger S. Cayeux T. Blankenstein C. Hilmes J. Karbach U. Moebius A. Knuth C. Huber B. Seliger 01. Januar 1998 / J Immunol Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors G. Noffz Z.H. Qin M. Kopf T. Blankenstein 01. Januar 1998 / Gene Ther Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation J. Westermann A. Aicher Z. Qin S. Cayeux K. Daemen T. Blankenstein B. Doerken A. Pezzutto 01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 02. Januar 2019 / J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein 01. April 2019 / Leukemia Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies N. Çakmak-Görür J. Radke S. Rhein E. Schumann G. Willimsky F.L. Heppner T. Blankenstein A. Pezzutto 02. September 2019 / BMC Bioinformatics SigsPack, a package for cancer mutational signatures F. Schumann E. Blanc C. Messerschmidt T. Blankenstein A. Busse D. Beule Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Seite 4 Nächste Seite Next › Letzte Seite Last »
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
01. Januar 1998 / Hum Gene Ther Strong immunogenic potential of a B7 retroviral expression vector: Generation of HLA-B7-restricted CTL response against selectable marker genes D. Jung E. Jaeger S. Cayeux T. Blankenstein C. Hilmes J. Karbach U. Moebius A. Knuth C. Huber B. Seliger
01. Januar 1998 / J Immunol Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors G. Noffz Z.H. Qin M. Kopf T. Blankenstein
01. Januar 1998 / Gene Ther Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation J. Westermann A. Aicher Z. Qin S. Cayeux K. Daemen T. Blankenstein B. Doerken A. Pezzutto
01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
02. Januar 2019 / J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
01. April 2019 / Leukemia Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies N. Çakmak-Görür J. Radke S. Rhein E. Schumann G. Willimsky F.L. Heppner T. Blankenstein A. Pezzutto
02. September 2019 / BMC Bioinformatics SigsPack, a package for cancer mutational signatures F. Schumann E. Blanc C. Messerschmidt T. Blankenstein A. Busse D. Beule